Enter assignee name

EPO Patents = 3

Forward Citations = 16

Loading Chart...

9 inventors (with patents filed for the assignee):

Seok Rye Choi (6 out of 7 patents)

Hank F Kung (6 out of 41 patents)

Zehui Wu (5 out of 5 patents)

4. Zhihao Zha (5 out of 5 patents)

5. Karl Ploessl (5 out of 6 patents)

6. Futao Liu (3 out of 3 patents)

7. Karl Plössl (1 out of 2 patents)

8. Zhihao Zha (1 out of 1 patent)

9. David Alexoff (1 out of 1 patent)

10. Zehui Wu (0 patent)

6 patents: Sort by Forward Citations

1. 12667630 - Radioactively labeled ligand for fibroblast activation protein-alpha imaging agent and preparation method therefor (2026-06-30),

2. 12544463 - Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application (2026-02-10),

3. 11071794 - Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application (2021-07-27),

4. 10912849 - Deuterium substituted positron emission tomography (PET) imaging agents and their pharmacological application (2021-02-09),

5. 10688200 - Urea-based prostate specific membrane antigen (PSMA) inhibitors for imaging and therapy (2020-06-23),

6. 10253052 - HBED-bisphosphonates, radiometal conjugates and their use as theranostic agents (2019-04-09),

Five Eleven Pharma Inc. is a leading pharmaceutical company specializing in the development and commercialization of innovative medicines. With a focus on rare diseases and personalized therapies, we are committed to improving the lives of patients worldwide. Our dedicated team of experts works tirelessly to bring groundbreaking treatments to market and drive positive outcomes for individuals in need.

Profile summary based on public USPTO records.